Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2019

Feb 21, 2019

33003_dirs_2019-02-21_9ebd22a2-0239-4c59-b866-430ee0489aff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-02-19

Reporting Person: HERSCHA LYNETTE (See Remark)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-19 Employee Stock Option (Right to Buy) $8.20 A 50000 Acquired 2029-02-19 Common Stock (50000) Direct

Footnotes

F1: This option was granted February 19, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.